:format(webp)/cdn.mskdoctors.com/storage/2026/7/p4I1DcXLxDW182tvBqgfJmV1W71YblUh.jpg)
OCA vs MACI for large knee cartilage defectsMACI (matrix-induced autologous chondrocyte implantation) is a surface repair requiring intact subchondral bone; osteochondral allograft (OCA) replaces both cartilage and bone. When knee cartilage defects breach underlying bone, OCA addresses what MACI cannot.MACI (matrix-induced autologous chondrocyte implantation) is a surface repair requiring intact subchondral bone; osteochondral allograft (OCA) replaces both cartilage and bone. When knee cartilage defects breach underlying bone, OCA addresses what MACI cannot.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/QrfuPSrluQSuTfY26E2s7bPfm9fOFncs.jpg)
ChondroFiller injection safety: what the evidence showsOver 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
:format(webp)/cdn.mskdoctors.com/storage/2026/7/8ilKw2XCH5pB5TWOt6kewJNVnwz4zE0V.jpg)
What the ChondroFiller evidence actually showsChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/74YTQQTyjHqGW0SCQyz2DVitXQ2VE6a3.jpg)
How single-stage ACI differs from MACIMACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.MACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/ETKg1ueF5BBKIau7DxGIoPsVzI5r2krh.jpg)
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/Z5ahPIurHVWU8aytBhy70twbvuGSfEAl.jpg)
ChondroFiller injection for hip cartilage defectsChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.ChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/UY0InSBaoOinSJHR9T3qmZrV7DMIQOXA.jpg)
ChondroFiller vs PRP for focal cartilage defectsFocal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying…Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/nJpuPYmYxVIJuCuke5TmcJtXlcYJxImS.jpg)
ChondroFiller or Arthrosamid for your kneeChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/SikVnK0CL8oEDHiTEBmScXvbSveyhmiA.jpg)
Single-stage or two-stage cartilage repairCartilage repair decisions hinge on defect size: lesions below roughly 1.5–2 cm² suit single-stage surgery, those of 2–4 cm² permit either approach, and larger defects typically require tissue replacement rather than repair.Cartilage repair decisions hinge on defect size: lesions below roughly 1.5–2 cm² suit single-stage surgery, those of 2–4 cm² permit either approach, and larger defects typically require tissue replacement rather than repair.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/AQZR5B1QMTa6MDznK1cq7XGkHnmvSm2W.jpg)
Choosing a ChondroFiller Specialist in the UKChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.ChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/kY3aOCrk3PYMR2xZRyN2DFXsNPQyzwu8.jpg)
What the ChondroFiller evidence actually showsChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
:format(webp)/cdn.mskdoctors.com/storage/2026/6/BHqWTZ0EoDO53RySglieS2V8xkzxUD9H.jpg)
ChondroFiller duration vs hyaluronic acid and ArthrosamidChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.
